Chief Executive Officer and co-founder
Alan Joslyn, PhD
More than thirty years of pharmaceutical leadership, including service as chairman and chief executive of Inimmune, president and chief executive of Oragenics, a director of Synergy Pharmaceuticals, and a worldwide product leader at Johnson & Johnson.
Chief Science Officer and co-founder
Del Potter, PhD
Inventor of the BioUnbound delivery platform. Joint UCSF and UC Berkeley PhD in neuropharmacology, with four decades in pharmaceutical formulation and delivery science, including work with 3M and Catalent, and direction of Phase 1 and Phase 2 clinical trials.